A new clinical challenge: supporting patients coping with the long-term effects of COVID-19.
Neal C GoldbergSabrina PoirierAllison KanasLisa McCorkellCarrie Anna McGinnYochai Re'emKathi KuehnelNina MuirheadTahlia RuschioniSusan Taylor-BrownLeonard A JasonPublished in: Fatigue : biomedicine, health & behavior (2022)
Mental Health Practitioners (MHPs) have a unique opportunity to provide resources and support to those suffering from Long COVID (LC), the post infectious illness that often follows an acute SARS-CoV-2 infection. In working with these individuals, MHPs can learn from the experiences of patients with another post-infectious disease known as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). ME/CFS was once thought to be a psychologically mediated disorder caused by deconditioning and the fear of exertion following a precipitating event such as a viral infection. Research now shows that LC and ME/CFS are biomedical, multisystem, complex physiologic diseases. This article provides a framework to MHPs for the treatment of LC patients using knowledge derived from three decades of research on ME/CFS.
Keyphrases
- mental health
- end stage renal disease
- coronavirus disease
- sars cov
- chronic kidney disease
- healthcare
- peritoneal dialysis
- prognostic factors
- depressive symptoms
- simultaneous determination
- mass spectrometry
- patient reported outcomes
- intensive care unit
- high resolution
- respiratory failure
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- sleep quality
- replacement therapy
- prefrontal cortex
- mental illness
- tandem mass spectrometry
- smoking cessation